English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT
Everest Medicines' Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
Oct 18, 2024 18:37 HKT
云顶新耀股价升两成 盈利潜力助力估值修复
Oct 18, 2024 18:31 HKT
雲頂新耀股價升兩成 盈利潛力助力估值修復
Oct 18, 2024 18:28 HKT
康哲藥業:蘆可替尼乳膏(白癜風)大灣區首批處方落地
Oct 18, 2024 14:54 HKT
康哲药业:芦可替尼乳膏(白癜风)大湾区首批处方落地
Oct 18, 2024 14:44 HKT
Fosun Secures EUR670 Million for Completion of Ageas Sale
Oct 16, 2024 15:36 HKT
復星已成功退出Ageas獲6.7億歐元
Oct 16, 2024 15:33 HKT
US Rate Cut and China Stimulus Ignite Fosun's Surge
Oct 15, 2024 11:50 HKT
减息周期展开 复星业务向好 股票及债券受惠
Oct 15, 2024 11:38 HKT
減息週期展開 復星業務向好 股票及債券受惠
Oct 15, 2024 11:32 HKT
金嗓子:高成長性持續兌現 長期回報股東凸顯投資價值
Oct 14, 2024 20:03 HKT
金嗓子:高成长性持续兑现 长期回报股东凸显投资价值
Oct 14, 2024 19:59 HKT
CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT
Empower your Heart Health with LAC This World Heart Day!
Oct 09, 2024 17:30 HKT
醫藥及醫療器械數字化解決方案明星升起 太美醫療科技在港上市
Oct 08, 2024 15:54 HKT
医药及医疗器械数字化解决方案明星升起 太美医疗科技在港上市
Oct 08, 2024 15:50 HKT
云顶新耀耐赋康®入选《2024版KDIGO指南草案》,中期业绩强劲增长,展现行业领军地位
Oct 03, 2024 14:42 HKT
NEFECON Included in 2024 KDIGO Clinical Practice Guidelines
Oct 02, 2024 10:18 HKT
云顶新耀耐赋康入选《2024版KDIGO指南草案》 中期业绩强劲增长 展现行业领军地位
Oct 02, 2024 10:14 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: